drugset / Trial / NCT05780515
A Study of ANX009 in Adult Participants With Lupus Nephritis
NaSingle-groupOpen-labelTreatment
Summary
The main purpose of this study is to determine the safety and tolerability of repeat doses of ANX009 in participants with lupus nephritis (LN).
Timeline
- Start
- 2022-08-09
- Primary completion
- 2023-08-31
- Completion
- 2023-10-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ANX009 | Protein / enzyme biologic | — | Subcutaneous |